Skip to main content
Clinical Trials/NCT05067465
NCT05067465
Completed
Not Applicable

Screening to Validate and Identify Nutrition-related Biomarkers for Definded Food Groups (Dairy Products, Whole Grain, Processed Meat, Vegetarian Sausage Alternatives)

University of Jena1 site in 1 country160 target enrollmentOctober 14, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy Lifestyle
Sponsor
University of Jena
Enrollment
160
Locations
1
Primary Endpoint
Fatty acids, concentration in %fatty acid methyl esters
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The Biomarker study will be conducted (i) to establish biomarker profiles that reflect the daily diet and regularly dietary habits, (ii) to complement self-reported dietary habits and (iii) to reduce gaps between self-reported information and real dietary intake. The study aims to assess relationships between defined nutrient intake (four groups: 1. Milk and dairy products, 2. Whole-grain products (rich in soluble fibers), 3. Sausage and processed meat (pork), 4. Meat-free sausage and meat alternatives (based on egg, soy) and resulting biochemical markers in human samples (plasma, serum, 24 h urine). In a next step, we will focus on unraveling the connection of the established diet-related metabolites with biomarkers of health and disease status, with focus on cardiovascular diseases (CVD).

Detailed Description

Within the scope of the present study, biomarkers or biomarker profiles are to be identified which reflect the daily diet and eating habits (focus: mixed diet / Western diet, vegetarians, vegans) in order to supplement or complete the information from diet protocols. The chosen study design enables relationships between a defined nutrient intake in the form of a standardized diet over five days (four groups with 40 subjects each; group 1: Milk and dairy products, group 2: Whole grain products (rich in soluble fiber), group 3: Sausage and processed meat (pork), group 4: Meat-free sausage and meat alternatives (based on egg, soy) and the resulting biochemical markers in the human samples (plasma, serum, whole blood, 24-hour urine). In addition, one subgroup (n = 12) consumed a test meal with the study foods on day 6 after the 5-day standardized diet. Before the test meal (time 0) and at intervals of 30, 60, 120, 180 min, blood samples are taken (postprandial profiling) in order to examine the brief increase in nutrients from the study foods in the human samples. The aim of the study is i) to validate already established biomarkers and ii) to identify new biomarkers / patterns. In the further course of the study, the identified and validated nutrition-associated biomarkers are to be linked to parameters of the health and disease status, whereby in particular the connection to cardiovascular risk factors and endpoints is considered. Furthermore, the study design enables an assessment of the physiological effects as a result of an increased intake of the selected food (groups).

Registry
clinicaltrials.gov
Start Date
October 14, 2021
End Date
February 28, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Jena
Responsible Party
Principal Investigator
Principal Investigator

Christine Dawczynski,PhD

PhD

University of Jena

Eligibility Criteria

Inclusion Criteria

  • Females (before menopause) and males
  • Age: 20 \< 40 years
  • BMI ≥ 18 \< 25 kg/m2
  • Participants must be subjectively healthy
  • Compatibility to one of the four planned groups as confirmed by lifestyle and nutrition-related questionnaires plus food frequency protocol (FFP) over five days
  • Precondition: stable eating habits at least one year before enrollment

Exclusion Criteria

  • Subjects with any acute or chronic disease (tumor, infection, other), gastrointestinal diseases, dia-betes mellitus (type I, II), chronic renal disease, diseases of the parathyroid, diseases necessitating regular phlebotomies
  • Intake of additional dietary supplements (e.g. fish oil capsules, vitamins, minerals etc.)
  • Weight loss or weight gain (\> 3 kg) during the last three months before study begin
  • Pregnancy or lactation
  • Transfusion of blood in the last three months before blood sample taking

Outcomes

Primary Outcomes

Fatty acids, concentration in %fatty acid methyl esters

Time Frame: Change from baseline after 5 days of the standardised diet

Fatty acids distribution in plasma lipids, inclusive odd-chain fatty acids

Secondary Outcomes

  • Homoarginine, concentration(Change from baseline after 5 days of the standardised diet)
  • Trimethylamine N-oxide, concentration(Change from baseline after 5 days of the standardised diet)
  • Galactonate, concentration(Change from baseline after 5 days of the standardised diet)
  • Galactono-1,5-lactone, concentration(Change from baseline after 5 days of the standardised diet)
  • 1-methylhistidineanserine, concentration(Change from baseline after 5 days of the standardised diet)
  • Galactitol, concentration(Change from baseline after 5 days of the standardised diet)
  • 3-methylhistidineanserine, concentration(Change from baseline after 5 days of the standardised diet)
  • Syringol sulfate, concentration(Change from baseline after 5 days of the standardised diet)
  • Wheat germ agglutinin, concentration(Change from baseline after 5 days of the standardised diet)
  • 3-phenyllactic acid, concentration(Change from baseline after 5 days of the standardised diet)
  • Asymmetric dimethylarginine, concentration(Change from baseline after 5 days of the standardised diet)
  • Alkylresorcinol, concentration(Change from baseline after 5 days of the standardised diet)

Study Sites (1)

Loading locations...

Similar Trials